Mohammad Obada Alsadi , Massa Saker , Sara Elias , Tareq Kaelooh , Asmaa Alrefai , Mohammad Sattouf
{"title":"A rare case of desmoplastic medulloblastoma in a 65-year-old male: A case report on achieving stability post-grade IV surgical resection","authors":"Mohammad Obada Alsadi , Massa Saker , Sara Elias , Tareq Kaelooh , Asmaa Alrefai , Mohammad Sattouf","doi":"10.1016/j.ijscr.2025.111294","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Medulloblastoma (MB) is an aggressive cerebellar tumor. In adults, it mainly occurs in the cerebellar hemispheres with desmoplastic traits, constituting 0.4 %–1 % of central nervous system tumors, primarily affecting individuals under 40. Cases above 60 are rare. Recent treatments have improved prognosis, with a 75 %–80 % five-year survival rate.</div></div><div><h3>Case presentation</h3><div>A 65-year-old man with no medical history presented with intermittent vertigo, progressive headaches, and morning nausea. MRI showed an enhancing desmoplastic medulloblastoma (WHO Grade IV) in the right cerebellar hemisphere. Successful total excision was performed without neurological deficits. Pathology confirmed the diagnosis, followed by chemotherapy and radiotherapy. Postoperative MRI showed complete resection with no spinal metastases. Over four years, the patient remained asymptomatic and stable.</div></div><div><h3>Discussion</h3><div>Medulloblastoma is rare in adults, presenting with cerebellar dysfunction and elevated intracranial pressure. Imaging and multimodal treatment, including surgery and adjuvant therapy, ensure improved outcomes, as seen in our patient's long-term remission.</div></div><div><h3>Conclusion</h3><div>This case highlights the importance of considering medulloblastoma in differential diagnoses for older patients with cerebellar symptoms and the success of multimodality treatment.</div></div>","PeriodicalId":48113,"journal":{"name":"International Journal of Surgery Case Reports","volume":"130 ","pages":"Article 111294"},"PeriodicalIF":0.6000,"publicationDate":"2025-04-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Surgery Case Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2210261225004808","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Medulloblastoma (MB) is an aggressive cerebellar tumor. In adults, it mainly occurs in the cerebellar hemispheres with desmoplastic traits, constituting 0.4 %–1 % of central nervous system tumors, primarily affecting individuals under 40. Cases above 60 are rare. Recent treatments have improved prognosis, with a 75 %–80 % five-year survival rate.
Case presentation
A 65-year-old man with no medical history presented with intermittent vertigo, progressive headaches, and morning nausea. MRI showed an enhancing desmoplastic medulloblastoma (WHO Grade IV) in the right cerebellar hemisphere. Successful total excision was performed without neurological deficits. Pathology confirmed the diagnosis, followed by chemotherapy and radiotherapy. Postoperative MRI showed complete resection with no spinal metastases. Over four years, the patient remained asymptomatic and stable.
Discussion
Medulloblastoma is rare in adults, presenting with cerebellar dysfunction and elevated intracranial pressure. Imaging and multimodal treatment, including surgery and adjuvant therapy, ensure improved outcomes, as seen in our patient's long-term remission.
Conclusion
This case highlights the importance of considering medulloblastoma in differential diagnoses for older patients with cerebellar symptoms and the success of multimodality treatment.